What’s Next For Amwell After 55% Growth From IPO Price?

Amwell,a telehealth company that went public recently, is now valued at about $6.5 billion, or about $28 per share, implying 55% gains from its IPO price of $18 a share. The company trades at 18x trailing Revenues largely in-line with some other telehealth companies…

About the Author

has written 23527 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com